PCS-2023 > 3 > 3E > 3E0 > 3E09 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E09 | Introduction, Nose | |
3E093 | Percutaneous | |
3E0930 | Antineoplastic | |
3E09305 | Introduction of Other Antineoplastic into Nose, Percutaneous Approach | |
3E0930M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach | |
3E0932 | Anti-infective | |
3E09328 | Introduction of Oxazolidinones into Nose, Percutaneous Approach | |
3E09329 | Introduction of Other Anti-infective into Nose, Percutaneous Approach | |
3E0933 | Anti-inflammatory | |
3E0933Z | Introduction of Anti-inflammatory into Nose, Percutaneous Approach | |
3E0934 | Serum, Toxoid and Vaccine | |
3E0934Z | Introduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach | |
3E093B | Anesthetic Agent | |
3E093BZ | Introduction of Anesthetic Agent into Nose, Percutaneous Approach | |
3E093H | Radioactive Substance | |
3E093HZ | Introduction of Radioactive Substance into Nose, Percutaneous Approach | |
3E093K | Other Diagnostic Substance | |
3E093KZ | Introduction of Other Diagnostic Substance into Nose, Percutaneous Approach | |
3E093N | Analgesics, Hypnotics, Sedatives | |
3E093NZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach | |
3E093T | Destructive Agent | |
3E093TZ | Introduction of Destructive Agent into Nose, Percutaneous Approach | |
3E093G | Other Therapeutic Substance | |
3E093GC | Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach | |
3E097 | Via Natural or Artificial Opening | |
3E0970 | Antineoplastic | |
3E09705 | Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening | |
3E0970M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening | |
3E0972 | Anti-infective | |
3E09728 | Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening | |
3E09729 | Introduction of Other Anti-infective into Nose, Via Natural or Artificial Opening | |
3E0973 | Anti-inflammatory | |
3E0973Z | Introduction of Anti-inflammatory into Nose, Via Natural or Artificial Opening | |
3E0974 | Serum, Toxoid and Vaccine | |
3E0974Z | Introduction of Serum, Toxoid and Vaccine into Nose, Via Natural or Artificial Opening | |
3E097B | Anesthetic Agent | |
3E097BZ | Introduction of Anesthetic Agent into Nose, Via Natural or Artificial Opening | |
3E097H | Radioactive Substance | |
3E097HZ | Introduction of Radioactive Substance into Nose, Via Natural or Artificial Opening | |
3E097K | Other Diagnostic Substance | |
3E097KZ | Introduction of Other Diagnostic Substance into Nose, Via Natural or Artificial Opening | |
3E097N | Analgesics, Hypnotics, Sedatives | |
3E097NZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, Via Natural or Artificial Opening | |
3E097T | Destructive Agent | |
3E097TZ | Introduction of Destructive Agent into Nose, Via Natural or Artificial Opening | |
3E097G | Other Therapeutic Substance | |
3E097GC | Introduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Opening | |
3E09X | External | |
3E09X0 | Antineoplastic | |
3E09X05 | Introduction of Other Antineoplastic into Nose, External Approach | |
3E09X0M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach | |
3E09X2 | Anti-infective | |
3E09X28 | Introduction of Oxazolidinones into Nose, External Approach | |
3E09X29 | Introduction of Other Anti-infective into Nose, External Approach | |
3E09X3 | Anti-inflammatory | |
3E09X3Z | Introduction of Anti-inflammatory into Nose, External Approach | |
3E09X4 | Serum, Toxoid and Vaccine | |
3E09X4Z | Introduction of Serum, Toxoid and Vaccine into Nose, External Approach | |
3E09XB | Anesthetic Agent | |
3E09XBZ | Introduction of Anesthetic Agent into Nose, External Approach | |
3E09XH | Radioactive Substance | |
3E09XHZ | Introduction of Radioactive Substance into Nose, External Approach | |
3E09XK | Other Diagnostic Substance | |
3E09XKZ | Introduction of Other Diagnostic Substance into Nose, External Approach | |
3E09XN | Analgesics, Hypnotics, Sedatives | |
3E09XNZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, External Approach | |
3E09XT | Destructive Agent | |
3E09XTZ | Introduction of Destructive Agent into Nose, External Approach | |
3E09XG | Other Therapeutic Substance | |
3E09XGC | Introduction of Other Therapeutic Substance into Nose, External Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |